{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:04:38Z","timestamp":1766901878304,"version":"3.48.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10995-1","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:48:07Z","timestamp":1757407687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the tumor microenvironment in colorectal cancer: the effect of Rapamycin on angiogenesis, apoptosis, and STAT5A\/TORC1 signaling"],"prefix":"10.1007","volume":"52","author":[{"given":"Atena","family":"Mansouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parichehreh","family":"Yaghmaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ghobeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Kadivar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"1","key":"10995_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10995_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/JCO.22.00046","volume":"41","author":"D Morton","year":"2023","unstructured":"Morton D et al (2023) Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial. J Clin Oncol 41(8):1541\u20131552","journal-title":"J Clin Oncol"},{"issue":"6","key":"10995_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","volume":"22","author":"M Labrie","year":"2022","unstructured":"Labrie M et al (2022) Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nat Rev Cancer 22(6):323\u2013339","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10995_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374\u2013403","journal-title":"Cancer Cell"},{"key":"10995_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.668731","volume":"11","author":"H Raskov","year":"2021","unstructured":"Raskov H et al (2021) Cancer-associated fibroblasts and tumor-associated macrophages in cancer and cancer immunotherapy. Front Oncol 11:668731","journal-title":"Front Oncol"},{"key":"10995_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061399","author":"RS Joshi","year":"2021","unstructured":"Joshi RS et al (2021) The role of Cancer-Associated fibroblasts in tumor progression. Cancers (Basel) 13(6):1399. https:\/\/doi.org\/10.3390\/cancers13061399","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10995_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41417-021-00318-4","volume":"28","author":"Q Ping","year":"2021","unstructured":"Ping Q et al (2021) Cancer-associated fibroblasts: overview, progress, challenges, and directions. Cancer Gene Ther 28(9):984\u2013999","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"10995_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/cbin.12004","volume":"47","author":"D Aden","year":"2023","unstructured":"Aden D et al (2023) Cancer-associated fibroblasts: is it a key to an intricate lock of tumorigenesis? Cell Biol Int 47(5):859\u2013893","journal-title":"Cell Biol Int"},{"key":"10995_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030703","author":"M Sirico","year":"2023","unstructured":"Sirico M et al (2023) Current state and future challenges for PI3K inhibitors in cancer therapy. Cancers (Basel) 15(3):703. https:\/\/doi.org\/10.3390\/cancers15030703","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10995_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/cas.16063","volume":"115","author":"Z Yang","year":"2024","unstructured":"Yang Z et al (2024) Anti-angiogenesis in colorectal cancer therapy. Cancer Sci 115(3):734\u2013751","journal-title":"Cancer Sci"},{"issue":"1","key":"10995_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang F et al (2024) Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol Oncol 17(1):80","journal-title":"J Hematol Oncol"},{"key":"10995_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113336","author":"D Basak","year":"2020","unstructured":"Basak D, Uddin MN, Hancock J (2020) The role of oxidative stress and its counteractive utility in colorectal cancer (CRC). Cancers (Basel) 12(11):3336. https:\/\/doi.org\/10.3390\/cancers12113336","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10995_CR13","doi-asserted-by":"publisher","first-page":"10623","DOI":"10.1007\/s00432-023-04914-9","volume":"149","author":"XY Wu","year":"2023","unstructured":"Wu XY, Zhu Z, Gai MH (2023) Prognostic modelling of colorectal cancer based on oxidative stress-related genes. J Cancer Res Clin Oncol 149(12):10623\u201310631","journal-title":"J Cancer Res Clin Oncol"},{"key":"10995_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17050752","author":"T Catalano","year":"2025","unstructured":"Catalano T et al (2025) The role of reactive oxygen species in colorectal cancer initiation and progression: perspectives on theranostic approaches. Cancers (Basel) 17(5):752. https:\/\/doi.org\/10.3390\/cancers17050752","journal-title":"Cancers (Basel)"},{"key":"10995_CR15","doi-asserted-by":"publisher","first-page":"1407449","DOI":"10.3389\/fimmu.2024.1407449","volume":"15","author":"W Liu","year":"2024","unstructured":"Liu W et al (2024) The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research. Front Immunol 15:1407449","journal-title":"Front Immunol"},{"key":"10995_CR16","doi-asserted-by":"crossref","unstructured":"Cao Y et al (2021) An Oxidative Stress Index-Based Score for Prognostic Prediction in Colorectal Cancer Patients Undergoing Surgery. Oxid Med Cell Longev, 2021: p. 6693707","DOI":"10.1155\/2021\/6693707"},{"issue":"1","key":"10995_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41419-025-07832-5","volume":"16","author":"E Astanina","year":"2025","unstructured":"Astanina E et al (2025) Post-translational modification of transcription factors: perspectives in vascular medicine. Cell Death Dis 16(1):520","journal-title":"Cell Death Dis"},{"issue":"12","key":"10995_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41580-023-00641-8","volume":"24","author":"C Goul","year":"2023","unstructured":"Goul C, Peruzzo R, Zoncu R (2023) The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat Rev Mol Cell Biol 24(12):857\u2013875","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10995_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A et al (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22(1):138","journal-title":"Mol Cancer"},{"key":"10995_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","volume":"67","author":"IA Mayer","year":"2016","unstructured":"Mayer IA, Arteaga CL (2016) The PI3K\/AKT pathway as a target for cancer treatment. Annu Rev Med 67:11\u201328","journal-title":"Annu Rev Med"},{"key":"10995_CR21","doi-asserted-by":"publisher","first-page":"1507621","DOI":"10.3389\/fcell.2024.1507621","volume":"12","author":"P Li","year":"2024","unstructured":"Li P, Huang D (2024) Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential. Front Cell Dev Biol 12:1507621","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"10995_CR22","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.7150\/thno.56747","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) The double-edged roles of ROS in cancer prevention and therapy. Theranostics 11(10):4839\u20134857","journal-title":"Theranostics"},{"key":"10995_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595818","volume":"11","author":"E Aydin","year":"2020","unstructured":"Aydin E et al (2020) Phosphoinositide 3-kinase signaling in the tumor microenvironment: what do we need to consider when treating chronic lymphocytic leukemia with PI3K inhibitors? Front Immunol 11:595818","journal-title":"Front Immunol"},{"issue":"1","key":"10995_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q et al (2024) Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Ther 9(1):266","journal-title":"Signal Transduct Target Ther"},{"key":"10995_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030312","author":"Y Hong","year":"2024","unstructured":"Hong Y et al (2024) Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox13030312","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10995_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01442-3","volume":"8","author":"M You","year":"2023","unstructured":"You M et al (2023) Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther 8(1):196","journal-title":"Signal Transduct Target Ther"},{"issue":"37","key":"10995_CR27","doi-asserted-by":"publisher","first-page":"62759","DOI":"10.18632\/oncotarget.18663","volume":"8","author":"HR Qian","year":"2017","unstructured":"Qian HR et al (2017) Interplay between apoptosis and autophagy in colorectal cancer. Oncotarget 8(37):62759\u201362768","journal-title":"Oncotarget"},{"key":"10995_CR28","doi-asserted-by":"publisher","unstructured":"Tossetta G et al (2022) Role of NRF2 in ovarian cancer. Antioxid (Basel) 11(4):663. https:\/\/doi.org\/10.3390\/antiox11040663","DOI":"10.3390\/antiox11040663"},{"issue":"1","key":"10995_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010016","volume":"17","author":"L Liu","year":"2024","unstructured":"Liu L, Graff SL, Wang Y (2024) New emerging therapies targeting PI3K\/AKT\/mTOR\/PTEN pathway in hormonal receptor-positive and HER2-negative breast cancer-current state and molecular pathology perspective. Cancers (Basel) 17(1):16. https:\/\/doi.org\/10.3390\/cancers17010016","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10995_CR30","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1158\/1078-0432.CCR-19-2485","volume":"26","author":"F Ganci","year":"2020","unstructured":"Ganci F et al (2020) PI3K inhibitors curtail MYC-dependent mutant p53 gain-of-function in head and neck squamous cell carcinoma. Clin Cancer Res 26(12):2956\u20132971","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10995_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01099-2","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao Z et al (2025) Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. J Biomed Sci 32(1):7","journal-title":"J Biomed Sci"},{"key":"10995_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.91010","author":"LH Nguyen","year":"2024","unstructured":"Nguyen LH et al (2024) The mTOR pathway genes MTOR, rheb, Depdc5, pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function. Elife 12:RP91010. https:\/\/doi.org\/10.7554\/eLife.91010","journal-title":"Elife"},{"key":"10995_CR33","doi-asserted-by":"publisher","first-page":"1589678","DOI":"10.3389\/fimmu.2025.1589678","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang H et al (2025) The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients. Front Immunol 16:1589678","journal-title":"Front Immunol"},{"key":"10995_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1476092","volume":"16","author":"W Jin","year":"2025","unstructured":"Jin W et al (2025) Identification of cancer-associated fibroblast signature genes for prognostic prediction in colorectal cancer. Front Genet 16:1476092","journal-title":"Front Genet"},{"issue":"9","key":"10995_CR35","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1038\/s41596-024-00998-w","volume":"19","author":"SI De Vleeschauwer","year":"2024","unstructured":"De Vleeschauwer SI et al (2024) Observe: guidelines for the refinement of rodent cancer models. Nat Protoc 19(9):2571\u20132596","journal-title":"Nat Protoc"},{"key":"10995_CR36","doi-asserted-by":"publisher","unstructured":"George S, Abrahamse H (2020) Redox potential of antioxidants in cancer progression and prevention. Antioxid (Basel) 9(11):1156. https:\/\/doi.org\/10.3390\/antiox9111156","DOI":"10.3390\/antiox9111156"},{"issue":"1","key":"10995_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01250-3","volume":"15","author":"Y Yan","year":"2024","unstructured":"Yan Y et al (2024) Autophagy regulates apoptosis of colorectal cancer cells based on signaling pathways. Discover Oncol 15(1):367","journal-title":"Discover Oncol"},{"key":"10995_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116883","volume":"176","author":"M Jia","year":"2024","unstructured":"Jia M et al (2024) Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment. Biomed Pharmacother 176:116883","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10995_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H et al (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6(1):263","journal-title":"Signal Transduct Target Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10995-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:02:26Z","timestamp":1766898146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10995-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10995"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10995-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No datasets were generated or analyzed during the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data access\u00a0"}}],"article-number":"875"}}